Sequenom to Webcast Analyst and Investor Briefing Presentation on September 23

Wednesday, September 24, 2008 General News J E 4
SAN DIEGO, Sept. 18 Sequenom (Nasdaq: SQNM)today announced that a live audio webcast and accompanying slide presentationwill be provided for its analyst and investor briefing event "Sequenom Analystand Investor Briefing." Details of the event are as follows:

Yury Khudyakov, Ph.D., Chief, Molecular Epidemiology and BioinformaticsLaboratory, Division of Viral Hepatitis, Centers for Disease Control andPrevention

"Novel Molecular Technologies for Public Health"

Betty Dragon, Ph.D., Sequenom Senior Vice President, Research &Development

"Noninvasive Prenatal Detection of Genetic Abnormalities UsingSEQureDx(TM) Technology"

Daniel H. Farkas, Ph.D., HCLD, FACB, Executive Director, Center forMolecular Medicine

"Real-world Genetic Testing: Translating Science into Routine ClinicalTests"

Jacob A. Canick, Ph.D., Professor of Pathology and Laboratory Medicine,Alpert Medical School at Brown University

"Design And Implementation of a Landmark, Multicenter, ProspectiveClinical Study To Validate The Safe And Accurate Detection of Down SyndromeUsing SEQureDx(TM) Technology"

Allan T. Bombard, M.D., FACOG, FACS, FACMG, reproductive geneticist,Chief Medical Officer, Sharp Mary Birch Hospital, and Chairman, ClinicalAdvisory Board

"Are We Facing a Revolution in Noninvasive Prenatal GeneticDiagnostics?"

How: Live over the Internet -- Simply log on to the Web at theaddress above.

About Sequenom

Sequenom is committed to providing the best genetic-analysis products forresearch and the molecular-diagnostic markets. The Company makes availablesuperior solutions for genomic science in biomedical research, livestock andagricultural applications and molecular medicine, as well as for variousdiagnostic markets, including noninvasive prenatal testing, oncology andinfectious diseases. Sequenom's proprietary MassARRAY(R) system deliversreliable and specific data from complex biological samples and from genetictarget materials available only in trace amounts.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from and at least a 56Kbps connection to the Internet. Ifyou experience problems listening to the webcast, send an e-mail SEQUENOM ANALYST AND INVESTOR BRIEFING When: Tuesday, September 23, 2008 at 4:30 p.m. Eastern time Where: (Logo: Agenda: Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc. "Sequenom Business Overview and Update" Presenters: Charles Cantor, Ph.D., Sequenom Chief Scientific Officer "The Future of Genetic and Genomic Analysis"

SOURCE Sequenom


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Affinion Group Announces Expansion of Insurance Se...
Randy Jackson and the American Heart Association E...